口服奥硝唑治疗急性冠周炎的临床疗效评价

目的临床观察奥硝唑治疗急性冠周炎的疗效，方法应用口服奥硝唑治疗37例急性冠周炎患者，以甲硝唑作为对照，检测了两组治疗前后盲袋内厌氧菌的变化及临床疗效。结果奥硝唑组和甲硝唑组对主要厌氧菌的杀菌率分别为91．7％和60．9％，对主要厌氧菌的抑菌率分别94．5％和68．2％（P〈O．01），奥硝唑组治疗急性冠周炎的临床疗效（有效率81．1％）也优于甲硝唑组（有效率38．7％），结论奥硝唑应成为急性冠周炎患者全身给药的首选药物。

Evaluation of the Effects of Oral Ornidazle on Acute Pericoronnitis

Objective Clinically observe the effects of Ornidazle on acute pericoronnitis patients.Methods 37 cases with acute pericoronnitis,who took Ornidazle orally,were compared with the control group,who took Metronidazole,to detect the changes of anaerobic bacteria in blind-sack and the clinical effects before and after treatment in the two groups.Results The bactericidal rate of Ornidazle group and Metronidazole group against anaerobic bacteria were 91.7% and 60.9%,respectively,and the bacteria controlling rate of the two groups were 94.5% and 68.2%,respectively(P<0.01).The treatment effect of Ornidazle group(81.1%) was better than that of the Metronidazole group(38.7%).Conclusion Ornidazle should become the priority medicine for an acute pericoronnitis patient.